查看购物车
  • Traditional Chinese
  • English
  • Japanese
基因检测市场（第 12 版）：全球市场分析，按应用、技术、产品和用户进行预测 - 附高管顾问指南（2026-2030 年）
市场调查报告书
商品编码
1826004

基因检测市场（第 12 版）：全球市场分析，按应用、技术、产品和用户进行预测 - 附高管顾问指南（2026-2030 年）

Genetic Testing Markets 12th Edition. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users. With Executive and Consultant Guides 2026 to 2030
出版日期: | 出版商: Howe Sound Research | 英文 568 Pages | 商品交期: 最快1-2个工作天内

价格

报告概述

无限的成长潜力？基因检测已经跨越了鸿沟，目前正在各个领域蓬勃发展。其中有哪些机会和陷阱？

我们才刚开始了解基因在健康和疾病中的作用。这些新知识加上价格下降，正在推动基因检测产业创纪录的成长。传统基因检测市场的检测量正在增加，检测范围也越来越广，这为产业带来了新的活力和课题。本报告对 14 个国家和 5 个地区进行了详细的细分。

预测性诊断？药物基因体学检测？直接面向消费者？透过揭秘术语，了解这项技术。有哪些课题？辨识机会和陷阱。了解五年成长预测和最终市场预测。

使用最新数据自信地做出投资决策和估值。

目录

第1章 市场指南

第2章 简介与市场定义

  • 本报告中基因检测的定义
  • 基因体学革命
  • 市场定义
  • 研究方法
  • 视角：医疗保健支出
  • 染色体、基因和表观遗传学

第3章 市场概要

  • 市场参与者
    • 学术研究机构
    • 诊断测试开发商
    • 测量设备供应商
    • 药品和试剂製造商
    • 病理供应商
    • 独立临床实验室
    • 公共、国家实验室
    • 医院实验室
    • 临床实验室
    • 审核机构
    • 认证机构
  • 基因检测类型、范例及注意事项
  • 产业结构

第4章 市场趋势

  • 成长促进因素
  • 阻碍成长的要素
  • 测量，自动化，诊断趋势

第5章 遗传基因检验的最近趋势

第6章 主要企业的简介

  • 10x Genomics, Inc.
  • 23andME Inc.
  • Abbott Laboratories
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agilent
  • Akonni Biosystems
  • Amoy Diagnostics Co., Ltd.
  • Ancestry.com LLC
  • Anchor Dx
  • Arrayit Corporation
  • ARUP Laboratories
  • Aus Diagnostics
  • BaseClear
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics(Danaher)
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • BioBam
  • Biocept, Inc.
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • BioGX
  • Biolidics Ltd
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Burning Rock
  • C2i Genomics
  • Cantata Bio
  • CareDx
  • Caris Molecular Diagnostics
  • Celemics
  • CellMax Life
  • Centogene
  • Cepheid(Danaher)
  • Circulogene
  • Clearbridge Biomedics
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics(MGI Tech)
  • CosmosID
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A.
  • DNAe
  • Easy DNA
  • Element Biosciences
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Excellerate Bioscience
  • Fabric Genomics
  • Freenome
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • Fulgent Genetics
  • Gene by Gene, Ltd.
  • Genedrive
  • GeneDx Holdings
  • GeneFirst Ltd.
  • Genetic Technologies Ltd.
  • Genetron Holdings
  • Genolution
  • Genomics England
  • Genomics Personalized Health(GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grifols
  • Guardant Health
  • Guardiome
  • Helix
  • Hologic
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Letsgetchecked
  • Lunglife AI Inc
  • Macrogen
  • MDNA Life SCIENCES, Inc.
  • MDx Health
  • Medgenome
  • Menarini Silicon Biosystems
  • Meridian Bioscience
  • Mesa Laboratories, Inc.
  • Metabiomics Corp
  • miR Scientific
  • NantHealth, Inc.
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New England Biolabs, Inc.
  • NGeneBio
  • Norgen Biotek Corp.
  • Novogene
  • Omega Bioservices
  • Oncocyte
  • OncoDNA
  • OpGen
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • PathoQuest S.A.
  • Personalis
  • PGDx(Labcorp)
  • Precipio
  • PrecisionMed
  • Predictive Oncology
  • Promega
  • Qiagen
  • QuantuMDx
  • Revvity
  • Roche Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sequencing.com
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc.
  • Singular Genomics
  • SkylineDx
  • Standard BioTools
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific
  • Ultima Genomics
  • Variantyx
  • Vela Diagnostics
  • VolitionRX
  • Zymo Research Corp

第7章 全球市场规模

  • 各国全球市场
  • 各用途全球市场
  • 各技术全球市场
  • 各产品全球市场
  • 各用户全球市场

第8章 全球遗传基因检验市场，各用途

  • 新生儿检验
  • NIPT
  • 预测检验
  • 肿瘤学检验
  • DTC检验
  • 其他

第9章 全球遗传基因检验市场，各技术

  • PCR检验
  • NGS
  • 细胞遗传学的检验
  • 其他

第10章 全球遗传基因检验市场，各产品

  • 设备
  • 试剂·套件
  • 软体
  • 服务

第11章 全球遗传基因检验市场，用户

  • 学术
  • 临床
  • 医药品
  • 产业以及其他

第12章 遗传基因检验的未来

第13章 附录

Report Overview:

Unlimited growth potential? Genetic Testing has crossed the chasm and is now growing in every area. What are the opportunities? What are the pitfalls?

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

  • 1.1. Genetic Testing - Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors
  • 1.4. Impact of Artificial Intelligence

2. Introduction and Market Definition

  • 2.1. Genetic Testing Definition in This Report
  • 2.2. The Genomics Revolution
  • 2.3. Market Definition
    • 2.3.1. Revenue Market Size.
    • 2.3.2. Newborn Screening
    • 2.3.3. Non Invasise Pregnancy Testing
    • 2.3.4. Predictive
    • 2.3.5. Oncology
    • 2.3.6. Direct to Consumer
    • 2.3.7. Other Application
    • 2.3.8. PCR
    • 2.3.9. NGS
    • 2.3.10. Cytogenetic
    • 2.3.11. Other Technology
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors
  • 2.5. Perspective: Healthcare Spending
    • 2.5.1. Global Healthcare Spending
    • 2.5.2. Spending on Healthcare and Pharmaceuticals
    • 2.5.3. Spending on Diagnostics
    • 2.5.4. Important Role of Insurance for Medical Services
  • 2.6. Chromosomes, Genes and Epigenetics
    • 2.6.1. Chromosomes
    • 2.6.2. Genes
    • 2.6.3. Epigenetics

3. Market Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Genetic Tests -Types, Examples and Discussion
    • 3.2.1. Preimplantation Genetic Diagnosis- An Emerging Market
    • 3.2.2. Prenatal Diagnosis - New Technologies Create Opportunity
    • 3.2.3. Newborn Screening
    • 3.2.4. Diagnostic Testing
    • 3.2.5. Carrier Testing
    • 3.2.6. Predictive and Presymptomatic Testing
    • 3.2.7. Pharmacogenomics
    • 3.2.8. Forensic Testing
    • 3.2.9. Parental Testing
    • 3.2.10. Ancestral Testing
  • 3.3. Industry Structure
    • 3.3.1. Hospital's Testing Share
    • 3.3.2. Economies of Scale
    • 3.3.3. Hospital vs. Central Lab
    • 3.3.4. Physician Office Lab's
    • 3.3.5. Physician's and POCT

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. Genetic Discoveries Impact.
    • 4.1.2. The Aging Effect
    • 4.1.3. Pharmacogenomics
    • 4.1.4. Oncology and Liquid Biopsy Factors
    • 4.1.5. Fertility Practice
    • 4.1.6. Direct to Consumer
  • 4.2. Factors Limiting Growth
    • 4.2.1. The Competition Effect
    • 4.2.2. The Cost Situation
    • 4.2.3. Testing usage analysis
    • 4.2.4. Wellness Effects
  • 4.3. Instrumentation, Automation and Diagnostic Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Genetic Testing Recent Developments

  • 5.1. Recent Developments
    • 5.1.1. Importance of This Section
    • 5.1.2. How to Use This Section
  • 5.2. Johns Hopkins Creates New Urine-based Cancer Test
  • 5.3. 23andMe's founder Anne Wojcicki wins bid for bankrupt DNA testing firm
  • 5.4. GeneDx Announces Completion of Fabric Genomics Acquisition
  • 5.5. QIAGEN acquires Genoox AI-powered software
  • 5.6 23andMe Launches New Genetic Report
  • 5.7. Natera Revenues Soar on Product Gains
    • 5.7.1. Tempus Completes Acquisition of Ambry Genetics
  • 5.8. GeneDx Launches Exome Testing for Epilepsy
  • 5.9. Owkin, AstraZeneca Partner to Develop AI Breast Cancer Prescreening Tool
  • 5.10. Myriad Genetics Reports Revenue Spike
  • 5.11. GeneDx Revenues Grow 45 Percent
  • 5.12. Revvity Launches NGS Panel for Newborn Screening
  • 5.13. LetsGetChecked: MyGeneticScreen
  • 5.14. Sysmex, Hitachi to Develop Low-Cost Sequencers
  • 5.15. Fore Genomics Offering WGS Newborn Screening to Parents
  • 5.16. Clinical Validation of Long-Read WGS Assay
  • 5.17. Resolution Bio Acquisition - Exact Sciences Aims at Liquid Biopsy Market
  • 5.18. Novitas Rescinds Coverage for Multiple Genetic Tests
  • 5.19. PerkinElmer (now Revvity) Becomes Dx Life Science Firm
  • 5.20. New POC Genotyping Tests Based on Electromagnetic Detection
  • 5.21. GenoMe Dx Launching dPCR Cancer Test
  • 5.22. mDetect To Trial Breast Cancer Liquid Biopsy
  • 5.23. Genomics England, Aims to Sequence 100K Newborns
  • 5.24. Juno Diagnostics NIPT With At-Home Sample Collection
  • 5.25. Cardio Diagnostics Launches Genetic Cario Risk Test
  • 5.26. Universal Genetic Testing in Breast Cancer Further Supported
  • 5.27. Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
  • 5.28. MyOme Lands Investment for WGS
  • 5.29. Type 2 Diabetes GWAS Enables Risk Prediction
  • 5.30. LetsGetChecked to Acquire Veritas Genetics
  • 5.31. Guardant Health Plans New Comprehensive Assay
  • 5.32. Tesis Labs Raises $20M
  • 5.33. Sema4: Sema4 Elements
  • 5.34. Clarified Precision Medicine Acquires Interpares Biomedicine
  • 5.35. Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
  • 5.36. Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
  • 5.37. NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology
  • 5.38. Progenity Revenues Fall on COVID-19 Effect
  • 5.39. Natera Launches Tumor Genomic Profiling Assay
  • 5.40. 23andMe To Go Public
  • 5.41. Guardant Health to Offer Tumor Tissue Sequencing
  • 5.42. Ancestry Quits Health Offering
  • 5.43. DTC Firm MyDNA Merges With Gene by Gene

6. Profiles of Key Companies

  • 6.1. 10x Genomics, Inc.
  • 6.2. 23andME Inc.
  • 6.3. Abbott Laboratories
  • 6.4. Adaptive Biotechnologies
  • 6.5. Admera Health, LLC
  • 6.6. Agilent
  • 6.7. Akonni Biosystems
  • 6.8. Amoy Diagnostics Co., Ltd.
  • 6.9. Ancestry.com LLC
  • 6.10. Anchor Dx
  • 6.11. Arrayit Corporation
  • 6.12. ARUP Laboratories
  • 6.13. Aus Diagnostics
  • 6.14. BaseClear
  • 6.15. Baylor Miraca Genetics Laboratories
  • 6.16. Beckman Coulter Diagnostics (Danaher)
  • 6.17. Becton, Dickinson and Company
  • 6.18. BGI Genomics Co. Ltd
  • 6.19. Bioarray Genetics
  • 6.20. BioBam
  • 6.21. Biocept, Inc.
  • 6.22. Biodesix Inc.
  • 6.23. BioFluidica
  • 6.24. BioGenex
  • 6.25. BioGX
  • 6.26. Biolidics Ltd
  • 6.27. bioMerieux Diagnostics
  • 6.28. Bioneer Corporation
  • 6.29. Bio-Rad Laboratories, Inc
  • 6.30. Bio-Techne
  • 6.31. Burning Rock
  • 6.32. C2i Genomics
  • 6.33. Cantata Bio
  • 6.34. CareDx
  • 6.35. Caris Molecular Diagnostics
  • 6.36. Celemics
  • 6.37. CellMax Life
  • 6.38. Centogene
  • 6.39. Cepheid (Danaher)
  • 6.40. Circulogene
  • 6.41. Clearbridge Biomedics
  • 6.42. Clinical Genomics
  • 6.43. Color Genomics
  • 6.44. Complete Genomics (MGI Tech)
  • 6.45. CosmosID
  • 6.46. Dante Labs
  • 6.47. Datar Cancer Genetics Limited
  • 6.48. Diasorin S.p.A.
  • 6.49. DNAe
  • 6.50. Easy DNA
  • 6.51. Element Biosciences
  • 6.52. Epic Sciences
  • 6.53. Epigenomics AG
  • 6.54. Eurofins Scientific
  • 6.55. Excellerate Bioscience
  • 6.56. Fabric Genomics
  • 6.57. Freenome
  • 6.58. FUJIFILM Wako Diagnostics
  • 6.59. Fujirebio
  • 6.60. Fulgent Genetics
  • 6.61. Gene by Gene, Ltd.
  • 6.62. Genedrive
  • 6.63. GeneDx Holdings
  • 6.64. GeneFirst Ltd.
  • 6.65. Genetic Technologies Ltd.
  • 6.66. Genetron Holdings
  • 6.67. Genolution
  • 6.68. Genomics England
  • 6.69. Genomics Personalized Health (GPH)
  • 6.70. GenomOncology
  • 6.71. Genzyme Corporation
  • 6.72. Grifols
  • 6.73. Guardant Health
  • 6.74. Guardiome
  • 6.75. Helix
  • 6.76. Hologic
  • 6.77. HTG Molecular Diagnostics
  • 6.78. Human Longevity, Inc.
  • 6.79. iCellate
  • 6.80. Illumina
  • 6.81. Incell Dx
  • 6.82. Inivata
  • 6.83. Invitae Corporation
  • 6.84. Invivoscribe
  • 6.85. Karius
  • 6.86. Letsgetchecked
  • 6.87. Lunglife AI Inc
  • 6.88. Macrogen
  • 6.89. MDNA Life SCIENCES, Inc.
  • 6.90. MDx Health
  • 6.91. Medgenome
  • 6.92. Menarini Silicon Biosystems
  • 6.93. Meridian Bioscience
  • 6.94. Mesa Laboratories, Inc.
  • 6.95. Metabiomics Corp
  • 6.96. miR Scientific
  • 6.97. NantHealth, Inc.
  • 6.98. Natera
  • 6.99. Nebula Genomics
  • 6.100. NeoGenomics
  • 6.101. New England Biolabs, Inc.
  • 6.102. NGeneBio
  • 6.103. Norgen Biotek Corp.
  • 6.104. Novogene
  • 6.105. Omega Bioservices
  • 6.106. Oncocyte
  • 6.107. OncoDNA
  • 6.108. OpGen
  • 6.109. Origene Technologies
  • 6.110. Oxford Nanopore Technologies
  • 6.111. Pacific Biosciences
  • 6.112. Panagene
  • 6.113. PathoQuest S.A.
  • 6.114. Personalis
  • 6.115. PGDx (Labcorp)
  • 6.116. Precipio
  • 6.117. PrecisionMed
  • 6.118. Predictive Oncology
  • 6.119. Promega
  • 6.120. Qiagen
  • 6.121. QuantuMDx
  • 6.122. Revvity
  • 6.123. Roche Diagnostics
  • 6.124. Roswell Biotechnologies
  • 6.125. Seegene
  • 6.126. Sequencing.com
  • 6.127. Siemens Healthineers
  • 6.128. simfo GmbH
  • 6.129. Singlera Genomics Inc.
  • 6.130. Singular Genomics
  • 6.131. SkylineDx
  • 6.132. Standard BioTools
  • 6.133. Sysmex
  • 6.134. Sysmex Inostics
  • 6.135. Tempus Labs, Inc.
  • 6.136. Thermo Fisher Scientific
  • 6.137. Ultima Genomics
  • 6.138. Variantyx
  • 6.139. Vela Diagnostics
  • 6.140. VolitionRX
  • 6.141. Zymo Research Corp

7. Global Market Size

  • 7.1. Global Market by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Country Market Shares
  • 7.2. Global Market by Application
    • 7.2.1. Table - Global Market by Application
    • 7.2.2. Chart - Application Share by Year
    • 7.2.3. Chart - Application Segment Growth Rates
    • 7.2.4. Chart - Application Segment Share Shifts
    • 7.2.5. Chart - Application Segment Share Base Year
    • 7.2.6. Chart - Application Segment Share Final Year
  • 7.3. Global Market by Technology
    • 7.3.1. Table - Global Market by Technology
    • 7.3.2. Chart - Technology Share by Year
    • 7.3.3. Chart - Technology Segment Growth Rates
    • 7.3.4. Chart - Technology Segment Share Shifts
    • 7.3.5. Chart - Technology Segment Share Base Year
    • 7.3.6. Chart - Technology Segment Share Final Year
  • 7.4. Global Market by Product
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Product Share by Year
    • 7.4.3. Chart - Product Segment Growth Rates
    • 7.4.4. Chart - Product Segment Share Shifts
    • 7.4.5. Chart - Product Segment Share Base Year
    • 7.4.6. Chart - Product Segment Share Final Year
  • 7.5. Global Market by User
    • 7.5.1. Table - Global Market by User
    • 7.5.2. Chart - User Share by Year
    • 7.5.3. Chart - User Segment Growth Rates
    • 7.5.4. Chart - User Segment Share Shifts
    • 7.5.5. Chart - User Segment Share Base Year
    • 7.5.6. Chart - User Segment Share Final Year

8. Market Sizes by Application

  • 8.1. Newborn Testing Market
    • 8.1.1. Table Newborn - by Country
    • 8.1.2. Chart - Newborn Growth
  • 8.2. NIPT Market
    • 8.2.1. Table NIPT - by Country
    • 8.2.2. Chart - NIPT Growth
  • 8.3. Predictive Testing Market
    • 8.3.1. Table Predictive - by Country
    • 8.3.2. Chart - Predictive Growth
  • 8.4. Oncology Testing Market
    • 8.4.1. Table Oncology - by Country
    • 8.4.2. Chart - Oncology Growth
  • 8.5. DTC Testing Market
    • 8.5.1. Table DTC - by Country
    • 8.5.2. Chart - DTC Growth
  • 8.6. Other Testing Market
    • 8.6.1. Table Other - by Country
    • 8.6.2. Chart - Other Growth

9. Global Genetic Testing Market by Technology

  • 9.1. PCR Testing Market
    • 9.1.1. Table PCR - by Country
    • 9.1.2. Chart - PCR Growth
  • 9.2. NGS Market
    • 9.2.1. Table NGS - by Country
    • 9.2.2. Chart - NGS Growth
  • 9.3. Cytogenetic Testing Market
    • 9.3.1. Table Cytogenetic - by Country
    • 9.3.2. Cytogenetic - Predictive Growth
  • 9.4. Other Testing Market
    • 9.4.1. Table Other - by Country
    • 9.4.2. Chart - Other Growth

10. Global Genetic Testing Market by Product

  • 10.1. Instruments Market
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instrument Growth
  • 10.2. Reagents and Kits Market
    • 10.2.1. Table Reagents and Kits - by Country
    • 10.2.2. Chart - Reagents and Kits Growth
  • 10.3. Software Market
    • 10.3.1. Table Software - by Country
    • 10.3.2. Software Growth
  • 10.4. Services Market
    • 10.4.1. Table Services - by Country
    • 10.4.2. Chart - Services Growth

11. Global Genetic Testing Market by User

  • 11.1. Academic Market
    • 11.1.1. Table Academic - by Country
    • 11.1.2. Chart - Academic Growth
  • 11.2. Clinical Market
    • 11.2.1. Table Clinical - by Country
    • 11.2.2. Chart - Clinical Growth
  • 11.3. Pharmaceutical Market
    • 11.3.1. Table Pharmaceutical - by Country
    • 11.3.2. Pharmaceutical - Predictive Growth
  • 11.4. Industrial and Other Market
    • 11.4.1. Table Industrial and Other - by Country
    • 11.4.2. Chart - Industrial and Other Growth

12. The Future of Genetic Testing

13. Appendices

  • 13.1. Growth of Approved IVD Test Menu
  • 13.2. Growth of Approved Average IVD Test Fee
  • 13.3. The Most Used IVD Assays
  • 13.4. The Highest Grossing Assays
  • 13.5. Laboratory Fees Schedule

Table of Tables

  • Table 1: Most Common Traditional Genetic Disorders
  • Table 2: The Base Pairs
  • Table 3: Market Players by Type
  • Table 4: The Different Types of Genetic Tests
  • Table 5: Five Factors Driving Growth
  • Table 6: Four Factors Limiting Growth
  • Table 7: Seven Key Diagnostic Laboratory Technology Trends
  • Table 8: Global Market by Country
  • Table 9: Global Market by Application
  • Table 10: Global Market by Technology
  • Table 11: Global Market by Product
  • Table 12: Global Market by User
  • Table 13: Newborn Segment by Country
  • Table 14: NIPT Segment by Country
  • Table 15: Predictive Segment by Country
  • Table 16: Oncology Segment by Country
  • Table 17: DTC Segment by Country
  • Table 18: Other Segment by Country
  • Table 19: PCR Segment by Country
  • Table 20: NGS Segment by Country
  • Table 21: Cytogenetic Segment by Country
  • Table 22: Other Segment by Country
  • Table 23: Instruments Segment by Country
  • Table 24: Reagents and Kits Segment by Country
  • Table 25: Software Segment by Country
  • Table 26: Services Segment by Country
  • Table 27: Academic Segment by Country
  • Table 28: Clinical Segment by Country
  • Table 29: Pharmaceutical Segment by Country
  • Table 30: Industrial and Other Segment by Country
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays
  • Table 33: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: DNA Strands and Chromosomes
  • Figure 3: Karyogram of Human Chromosomes
  • Figure 4: Size of Various Genomes
  • Figure 5: The Road to Diagnostics
  • Figure 6: The Changing Age of the World Population
  • Figure 7: Health Care Consumption by Age
  • Figure 8: Cancer Incidence - Age at Diagnosis
  • Figure 9: Centralized vs. Decentralized Laboratory Service
  • Figure 10: A Highly Multiplexed Syndromic Testing Unit
  • Figure 11: The Real Cost to Sequence the Human Genome
  • Figure 12: The Codevelopment Process
  • Figure 13: Comparing MDx Diagnostic and Traditional Testing
  • Figure 14: Country Market Shares
  • Figure 15: Application Share by Year
  • Figure 16: Application Segment Growth Rates
  • Figure 17: Segment Share Shifts
  • Figure 18: Application Segment Share Base Year
  • Figure 19: Application Segment Share Final Year
  • Figure 20: Technology Share by Year
  • Figure 21: Technology Segment Growth Rates
  • Figure 22: Technology Segment Share Shifts
  • Figure 23: Technology Segment Share Base Year
  • Figure 24: Technology Segment Share Final Year
  • Figure 25: Product Share by Year
  • Figure 26: Product Segment Growth Rates
  • Figure 27: Product Segment Share Shifts
  • Figure 28: Product Segment Share Base Year
  • Figure 29: Product Segment Share Final Year
  • Figure 30: User Share by Year
  • Figure 31: User Segment Growth Rates
  • Figure 32: User Segment Share Shifts
  • Figure 33: User Segment Share Base Year
  • Figure 34: User Segment Share Final Year
  • Figure 35: Newborn vs. Total Market Growth
  • Figure 36: NIPT vs. Total Market Growth
  • Figure 37: Predictive vs. Total Market Growth
  • Figure 38: Oncology vs. Total Market Growth
  • Figure 39: DTC vs. Total Market Growth
  • Figure 40: Other vs. Total Market Growth
  • Figure 41: PCR vs. Total Market Growth
  • Figure 42: NGS vs. Total Market Growth
  • Figure 43: Cytogenetic vs. Total Market Growth
  • Figure 44: Other vs. Total Market Growth
  • Figure 45: Instrument vs. Total Market Growth
  • Figure 46: Reagents and Kits vs. Total Market Growth
  • Figure 47: Software vs. Total Market Growth
  • Figure 48: Services vs. Total Market Growth
  • Figure 49: Academic vs. Total Market Growth
  • Figure 50: Clinical vs. Total Market Growth
  • Figure 51: Pharmaceutical vs. Total Market Growth
  • Figure 52: Industrial and Other vs. Total Market Growth
  • Figure 53: IVD Test Menu Growth
  • Figure 54: IVD Test Average Fees - A Ten Year View